PC: PIXABAY
Bhubaneswar: The Drugs Controller General of India (DCGI ) has granted restricted emergency use authorisation to Bharat Biotech’s Covaxin for children aged 6 to 12 years amid a surge in cases in schools, ANI news agency reported on Tuesday.
The company has been asked to submit safety data, including that on adverse events, with due analysis every 15 days for the first two months and monthly thereafter for five months, the India Today reported.
Last week, the Subject Expert Committee (SEC) of the DCGI had asked the Hyderabad-based firm for additional data on its vaccine for administering it to children aged between 2 and 12 years.
The DCGI has also granted emergency use authorisation to Corbevax for children between the age of 5 and 12 years, sources told ANI.
The panel had earlier approved Covaxin for emergency use in children above 12 years in December last year. Cadila Health’s ZyCoV-D has also received restricted emergency use authorisation for children above the age of 12 years, the news agency added.
Balangir: The recovery of a minor’s body from a hill near Jilialiti village under Lathor…
Noida: A housekeeping staffer at a private school in Noida, Uttar Pradesh, has been arrested…
Cuttack: Three vehicles reportedly got trapped after a huge electronic welcome gate installed by Khannagar…
Cuttack: Police on Friday exhumed the body of a man after his family members from…
New Delhi" The United Arab Emirates (UAE) has introduced a new visa-on-arrival policy, easing entry…
New Delhi: Alok Verma is set to become the next director in-charge of Steel Authority…
Bhubaneswar: Around 3.5 crore individuals will be benefitted from a merger of the Centre’s flagship…
Bengaluru: The Enforcement Directorate (ED) officials raided the office of Mysuru Urban Development Authority (MUDA)…